NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/08/2020
Back to search
Official data from USPTO
PHARMAPENDIUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMAPENDIUM
ST13
US500000077950192Class
9, 38, 41, 42
Filing
77950192
Registration
3896403
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/08/2020
Trademark type
Word
Nice classes
9, 38, 41, 42
Filing date
03/04/2010
Registration date
12/28/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/08/2020
Last transaction
09/08/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
11
Owner location
KIDLINGTON, OXFORD, GB
Examiner
GAAFAR, SAMIR MICHAEL
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ELSEVIER LIMITED
ELSEVIER LIFE SCIENCES IP LIMITED
RELX INTELLECTUAL PROPERTIES SA
REED ELSEVIER PROPERTIES SA
Elsevier Properties SA
Representatives
JULIA C. ARCHER ENNS & ARCHER LLP
Technical classification
Nice Classes
Class 9Class 38Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
COMPUTER PROGRAMS AND SOFTWARE USED FOR SEARCHING DATABASESFOR USE IN THE FIELDS OF DRUG DISCOVERY AND DEVELOPMENT; ELECTRONIC DOWNLOADABLE PUBLICATIONSBOOKS AND PERIODICAL PUBLICATIONSMAGAZINESJOURNALSNEWSPAPERSCATALOGS FEATURING TOPICS IN THE FIELDS OF DRUG DISCOVERY AND DEVELOPMENT ; ELECTRONIC PUBLICATIONSBOOKS AND PERIODICAL PUBLICATIONSMAGAZINESJOURNALSNEWSPAPERSCATALOGS FEATURING TOPICS IN THE FIELDS OF DRUG DISCOVERY AND DEVELOPMENT RECORDED ON COMPUTER MEDIA; DOWNLOADABLE COMPUTER SOFTWARE FOR PERFORMING DAILY TIME PLANNING FUNCTIONS; COMPUTER SOFTWARE FOR PERFORMING DAILY TIME PLANNING FUNCTIONSRECORDED ON COMPUTER DATA MEDIA
Class 38
Providing access to computer databases
Class 41
PUBLISHING OF ONLINE ELECTRONIC PUBLICATIONS; PUBLICATION OF TEXTSBOOKSMAGAZINES; PROVISION OF ONLINE PUBLICATIONSMAGAZINESJOURNALSBOOKS IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENTWHICH ONLINE PUBLICATIONS FEATURE A PUBLICATION NAVIGATION FUNCTION; PROVIDING EDUCATION INFORMATION IN THE FIELD OF TRAINING; EDUCATION SERVICESARRANGING AND CONDUCTING TRAINING WORKSHOPS IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENT; ORGANIZATION OF DEMONSTRATIONS AND EXHIBITIONS FOR EDUCATIONAL PURPOSES; EDUCATIONAL SERVICESORGANIZING COLLOQUIUMSCONVENTIONSSEMINARSWORKSHOPS AND TRAINING COURSES IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENT; EDUCATIONAL AND TRAINING SERVICESCONDUCTING CLASSESSEMINARSCONFERENCESWORKSHOPS IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENT; PROVIDING EDUCATION INFORMATION IN THE FIELD OF EDUCATIONAL DEMONSTRATIONS AND EXHIBITIONSCOLLOQUIUMSCONVENTIONSSEMINARSWORKSHOPS AND EDUCATIONAL EVENTS; PROVIDING INFORMATION AND CONSULTATION RELATING TO THE ORGANIZING OF EDUCATIONAL EXHIBITIONS AND COLLOQUIUMS FOR PARTICIPANTSVISITORS AND EXHIBITORSPROVIDED IN PERSON AND ELECTRONICALLY VIA A WEB SITE; PUBLISHING SERVICESDESKTOP PUBLISHING FOR OTHERSPUBLICATION OF PRINTED MATTER AND PUBLISHING OF ELECTRONIC PUBLICATIONS CONNECTED WITH PRESENTATIONS AND EXHIBITIONSCOLLOQUIUMSCONVENTIONSSEMINARSWORKSHOPS AND EVENTS OF AN EDUCATIONAL NATURE; ALL THE ABOVE MENTIONED SERVICES BEING RELATED TO DRUG DISCOVERY AND DEVELOPMENT
Class 42
SCIENTIFIC RESEARCH IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENT; INDUSTRIAL RESEARCH IN THE FIELD OF DRUG DISCOVERY AND DEVELOPMENT; WRITING OF DATA PROCESSING PROGRAMS; INSTALLATION OF COMPUTER NETWORKING SOFTWARE ON NETWORKED COMPUTERS; HOSTING OF WEB SITES; RENTAL OF COMPUTER SOFTWARE; CONSULTATION AND PROVIDING INFORMATION IN THE FIELD OF PHARMACEUTICAL DRUG DISCOVERY AND DEVELOPMENT
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/08/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/08/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
07/28/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/28/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/06/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/21/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/18/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/18/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/18/2017
E815
TEAS SECTION 8 & 15 RECEIVED
12/13/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/17/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/30/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
12/28/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2010
PUBO
PUBLISHED FOR OPPOSITION
10/12/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/09/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
09/09/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/09/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
09/09/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/09/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2010
ALIE
ASSIGNED TO LIE
08/28/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2010
GNRT
NON-FINAL ACTION E-MAILED
06/09/2010
CNRT
NON-FINAL ACTION WRITTEN
06/09/2010
DOCK
ASSIGNED TO EXAMINER
06/08/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
03/10/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2010
NWAP
NEW APPLICATION ENTERED
03/08/2010
Continuous trademark protection
Get notified about every new filing that threatens PHARMAPENDIUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.